Khiron Life Sciences Corp. reports that its wholly owned subsidiary, Khiron Colombia SAS, has been granted the first licence ever issued by the Ministry of Justice for the cultivation of medical cannabis in Colombia.
The granting of this licence positions the Company as the first grower of low tetrahydrocannabinol medical cannabis in the country, and enables the Company to produce low THC based extracts for domestic and international consumption.
The Company currently has two additional licence applications pending approval by the Ministry of Justice and Ministry of Health, and anticipates the issuance of these licences in the near term. These licences would enable the cultivation of high THC based cannabis and production of high THC based cannabis extracts.
Mr. Alvaro Torres, President and CEO of the Company, comments: “We are honored by the confidence bestowed upon us by the government of Colombia, and fully accept the responsibility to deliver on our commitment to produce quality products, support patients and healthcare professionals, and to be in full regulatory compliance. We are proud to be a leader in Colombia’s entrance to this emerging global industry. I would like to personally thank all members of our team for their tireless efforts in reaching this milestone. We look forward to continuing our dialogue with the government of Colombia to ensure the attainment of its objectives for the medical cannabis industry.”
credit:420intel.com
